Published in Drug Week, September 21st, 2007
"It is unknown which radiographic feature is most relevant for the assessment of change and the prediction of future damage in AS. To analyse radiographic progression in AS by using different assessments to define the most important changes. Spinal radiographs of 116 patients with AS were scored by the mSASSS at baseline ( BL) and after 2 years. Radiographic progression was assessed by differentiating ( 1) any change;...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.